MCM
CYRX icon

Marathon Capital Management’s CryoPort CYRX Stock Holding History

Marathon Capital Management’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
67,225
+10,000
+17% +$128K 0.21% 72
2026
Q1 		$474K Sell
57,225
-30,000
-34% -$271K 0.11% 107
2025
Q4 		$837K Sell
87,225
-22,775
-21% -$215K 0.18% 82
2025
Q3 		$1.04M Sell
110,000
-11,725
-10% -$98.7K 0.24% 70
2025
Q2 		$908K Buy
121,725
+33,045
+37% +$205K 0.23% 70
2025
Q1 		$539K Sell
88,680
-2,050
-2% -$14.2K 0.14% 87
2024
Q4 		$706K Sell
90,730
-49,730
-35% -$371K 0.18% 78
2024
Q3 		$1.14M Sell
140,460
-7,825
-5% -$64K 0.28% 65
2024
Q2 		$1.02M Sell
148,285
-4,700
-3% -$63.3K 0.26% 68
2024
Q1 		$2.71M Sell
152,985
-500
-0.3% -$7.92K 0.65% 40
2023
Q4 		$2.38M Sell
153,485
-23,315
-13% -$305K 0.6% 45
2023
Q3 		$2.42M Buy
176,800
+118,090
+201% +$1.74M 0.61% 46
2023
Q2 		$1.01M Sell
58,710
-11,665
-17% -$239K 0.25% 69
2023
Q1 		$1.69M Buy
70,375
+15,200
+28% +$331K 0.42% 58
2022
Q4 		$957K Buy
55,175
+20,475
+59% +$432K 0.26% 67
2022
Q3 		$845K Buy
34,700
+720
+2% +$24.8K 0.24% 73
2022
Q2 		$1.05M Buy
33,980
+2,100
+7% +$55.9K 0.34% 59
2022
Q1 		$1.11M Buy
31,880
+100
+0.3% +$3.78K 0.32% 57
2021
Q4 		$1.88M Sell
31,780
-2,600
-8% -$180K 0.44% 46
2021
Q3 		$2.29M Sell
34,380
-2,125
-6% -$131K 0.52% 41
2021
Q2 		$2.3M Buy
36,505
+150
+0.4% +$8.44K 0.53% 39
2021
Q1 		$1.89M Sell
36,355
-3,345
-8% -$203K 0.5% 38
2020
Q4 		$1.74M Sell
39,700
-7,150
-15% -$341K 0.51% 42
2020
Q3 		$2.22M Sell
46,850
-5,900
-11% -$239K 0.81% 24
2020
Q2 		$1.6M Sell
52,750
-12,600
-19% -$280K 0.61% 29
2020
Q1 		$1.11M Buy
65,350
+400
+0.6% +$7.01K 0.51% 34
2019
Q4 		$1.07M Buy
+64,950
New +$966K 0.36% 50

Other funds holding CYRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Marathon Capital Management's CYRX Position: Q2 2026 in Review

Marathon Capital Management increased its CryoPort (CYRX) stake by 17% in Q2 2026, buying an estimated $128K and bringing the position to 67,225 shares worth $1.06M. The position accounts for 0.21% of the portfolio, ranked #72.

Marathon Capital Management first reported a position in CYRX in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.71M in Q1 2024. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Marathon Capital Management held 67,225 shares of CryoPort worth $1.06M as of Q2 2026.
  • Marathon Capital Management bought 10,000 CryoPort shares in Q2 2026, an estimated $128K.
  • CryoPort made up 0.21% of Marathon Capital Management's portfolio in Q2 2026, its #72 holding.
  • Marathon Capital Management first reported a position in CryoPort in Q4 2019 and has held it in 27 quarters since.
  • Marathon Capital Management's CryoPort position peaked at $2.71M in Q1 2024.
  • 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Marathon Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.